- Home
- TRNR vs INM Comparison
TRNR vs INM Comparison
Compare TRNR & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRNR
- INM
- Stock Information
- Founded
- TRNR 2017
- INM 1981
- Country
- TRNR United States
- INM Canada
- Employees
- TRNR N/A
- INM N/A
- Industry
- TRNR Consumer Electronics/Appliances
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- TRNR Technology
- INM Health Care
- Exchange
- TRNR Nasdaq
- INM Nasdaq
- Market Cap
- TRNR 5.9M
- INM 5.0M
- IPO Year
- TRNR 2023
- INM N/A
- Fundamental
- Price
- TRNR $2.59
- INM $1.85
- Analyst Decision
- TRNR
- INM
- Analyst Count
- TRNR 0
- INM 0
- Target Price
- TRNR N/A
- INM N/A
- AVG Volume (30 Days)
- TRNR 68.9K
- INM 100.5K
- Earning Date
- TRNR 11-14-2025
- INM 11-13-2025
- Dividend Yield
- TRNR N/A
- INM N/A
- EPS Growth
- TRNR N/A
- INM N/A
- EPS
- TRNR N/A
- INM N/A
- Revenue
- TRNR $6,972,000.00
- INM $4,942,633.00
- Revenue This Year
- TRNR $578.14
- INM N/A
- Revenue Next Year
- TRNR $130.65
- INM N/A
- P/E Ratio
- TRNR N/A
- INM N/A
- Revenue Growth
- TRNR 373.32
- INM 7.50
- 52 Week Low
- TRNR $2.25
- INM $1.72
- 52 Week High
- TRNR $106.30
- INM $8.27
- Technical
- Relative Strength Index (RSI)
- TRNR 36.33
- INM 32.96
- Support Level
- TRNR $2.25
- INM $1.80
- Resistance Level
- TRNR $2.65
- INM $1.92
- Average True Range (ATR)
- TRNR 0.24
- INM 0.10
- MACD
- TRNR -0.02
- INM -0.03
- Stochastic Oscillator
- TRNR 29.40
- INM 10.87
About TRNR Interactive Strength Inc.
Interactive Strength Inc provides an integrated home fitness platform that allows its customers to participate in interactive wellness and strength-based training sessions. Its health coaching services encompass guidance and coaching on nutrition, recovery, sleep, and other health and lifestyle categories. The company generates revenue from sales of its connected fitness products, membership revenue, and personal training revenue.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.